Kyorin Pharma To Shut Down US Subsidiary ActivX

End Of Line For 2004 Acquisition

Kyorin decided to shut down its subsidiary ActivX
ActivX to end operations by 31 March 2023 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business